We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diatron MI and Medicon Hellas Sign Exclusive Supply Agreement

By LabMedica International staff writers
Posted on 14 Oct 2013
Diatron MI Plc (Budapest, Hungary) and Medicon Hellas SA (Gerakas, Greece) signed an exclusive supply agreement for an extensive range of high quality clinical chemistry reagents for use on the Diatron Pictus range of clinical chemistry analyzers in all international markets except the USA.

All reagents will be manufactured by Medicon Hellas, exclusively for Diatron and have been specifically designed with the Diatron analyzers in mind, so the combination of analyzer and reagents allows customers to employ features and benefits that are only normally possible on high cost clinical chemistry systems. The reagent range will initially consist of 60 test parameters (substrates, enzymes, electrolytes, and specific proteins), which have been developed to meet the needs and demands of today’s modern clinical chemistry laboratory to have precision, linearity, sensitivity, on-board stability, and calibration stability.

Diatron will be exhibiting two new, bench top analyzers at Medica, Dusseldorf (November 20–23, 2013). The new version of the established Abacus 3CT hematology analyzer has been enhanced to make it even easier to use. In addition, Diatron will also be previewing a prototype version of the brand new Pictus 500 clinical chemistry analyzer.

“ We are excited by the new collaboration with Medicon as it will allow us to mutually grow our clinical chemistry business with our global distributor partners and to demonstrate to end-users our commitment to provide them with the full package—a cost effective system (analyzer & reagent) with complete support,“ said Ronald Backes, vice president of International Business- Diatron MI Plc.

“Medicon is delighted to enter into this agreement with Diatron, rewarding the time and effort we have put into developing specific reagents and tests for the Pictus analyzers. We are pleased that customers around the world will now be able to benefit from what Greek laboratories have experienced with the analyzer/reagent combination,” commented Sakis Mitropoulos, director, customer services, Medicon Hellas SA.

Related Links:

Diatron MI
Medicon Hellas



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests